Clinical Trials Logo

Filter by:
NCT ID: NCT04881643 Completed - Clinical trials for Acceptability of Health Care

Blended Treatment för PTSD Feasibility Study

Start date: May 20, 2021
Phase: N/A
Study type: Interventional

Feasibility and pilot study using within-group design with the aim of examining whether the blended psychological treatment for PTSD is acceptable for patients and therapists. 20 patients will be included and 4 therapists. Semi-structured interviews will be conducted after treatment with a selection of therapists and patients with questions regarding the helpfulness and feasibility of the treatment. Effects of the treatment will be assessed via standardized self-report outcome measures regarding PTSD, depression, anxiety, sleep, quality of life, function and patient satisfaction / acceptance. Measurements are conducted before, during, immediately after and 6 months after treatment. The study is conducted at 2 psychiatric outpatient clinics in the Stockholm Region.

NCT ID: NCT04880681 Recruiting - Clinical trials for Prostate Cancer (Diagnosis)

Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle

Start date: May 17, 2021
Phase: N/A
Study type: Interventional

Patient-blinded randomized controlled trial evaluating length and quality of prostate biopsies taken by a novel biopsy needle.

NCT ID: NCT04879563 Active, not recruiting - Breast Cancer Clinical Trials

Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project

ASCAPE
Start date: February 1, 2021
Phase: Phase 2
Study type: Interventional

ASCAPE (Artificial intelligence Supporting CAncer Patients across Europe) is a collaborative research project involving 15 partners from 7 countries, including academic medical centers, SMEs (small and medium-sized enterprises), research centers and universities, aiming to leverage the recent advances in Big Data and AI (Artificial Intelligence) to support cancer patients' Quality of Life (QoL) and health status. Specifically, ASCAPE aims to provide personalized- and AI-based predictions for QoL issues in breast- and prostate cancer patients as well as suggest potential interventions to their physicians. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 875351.

NCT ID: NCT04878185 Active, not recruiting - Colorectal Cancer Clinical Trials

Optimizing Physical Function Before Cancer Surgery in Older People at Risk

CanOptiPhys
Start date: May 10, 2021
Phase: N/A
Study type: Interventional

This randomized controlled trial is a multicentre study designed to explore the effects of preoperative exercise on physical fitness, postoperative complications, recovery, and health-related quality of life in older individuals at risk scheduled to undergo colorectal cancer surgery. The hypothesis is that older patients with low preoperative physical capacity will benefit from preoperative exercise in terms of lower risk for postoperative complications and improved recovery after surgery.

NCT ID: NCT04877028 Completed - Frailty Clinical Trials

Frailty Screening in the Swedish Emergency Department Setting

Start date: May 17, 2021
Phase:
Study type: Observational

This prospective observational study will investigate the correlation of frailty in relation to serious outcomes. Serious outcomes are defined as: mortality within 30 days, admission to hospital, length of stay in the Emergency Department(ED), in hospital length of stay and revisits to the ED. The exposure, frailty, will be assessed according to Clinical Frailty Scale. ED patients >65 years of age in a Swedish regional health care system (Region Östergötland, Sweden) comprising three EDs in Linköping, Norrköping and Motala. The outcomes will be compared according to the degree of frailty and censored over 7, 30 and 90 days respectively.

NCT ID: NCT04876092 Active, not recruiting - Clinical trials for Lymphoma, Non-Hodgkin

A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL

Start date: July 28, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the safety and recommended Phase 2 dose (RP2D) of JNJ-67856633 and ibrutinib in combination in participants with B cell non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).

NCT ID: NCT04872920 Recruiting - Cushing Syndrome Clinical Trials

Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole.

KetoPASS
Start date: December 20, 2018
Phase:
Study type: Observational

This is a non-interventional, prospective, multinational, multicentre, observational study, in which data collected are those derived from routine clinical practice via an European registry on CS: ERCUSYN.

NCT ID: NCT04871568 Recruiting - Clinical trials for Jugular Vein Occlusion

Central Vein Stenosis Due to Dialysis Catheter Insertion in Subclavian Compared to Jugular Vein

CITES
Start date: November 15, 2021
Phase: N/A
Study type: Interventional

Central vein stenosis (CVS) is a well-known complication of central venous catheterization, especially after insertion of temporary hemodialysis catheters (tHDC). Incidence and prevalence differ between studies, and exact figures are hard to tell since proper venographies seldom are performed unless the patient is symptomatic. Most tHDC are placed in the jugular or femoral veins as catheters in the subclavian veins have been shown to result in CVS to a greater degree. However, some studies are equivocal and there are several advantages with the subclavian vein such as a lower risk for infectious and thrombotic complications, longer durability (thereby avoiding placement of a new catheter with repeated tissue trauma), increased comfort during insertion and use, less effect on blood flow if the patient moves the head, easier to mobilize. The studies on CVS incidence originate from the 1990s when ultrasound-guided insertions were unheard of and polyurethane catheters were prevalent. The investigators believe that there is less tissue trauma when using ultrasound guidance in real-time. Furthermore, CVS is less common when silicone catheters are used instead of polyurethane catheters. To avoid unnecessary vascular trauma and patient suffering, any pre-existing CVS should ideally be detected before cannulation attempts. A CT scan of the chest with IV contrast is preferred, but this exposes the patient to ionized radiation, is time-consuming and (although debated) may cause contrast-induced nephropathy. A brief ultrasound examination to verify central venous patency would be useful provided it is shown to have an adequate sensitivity for stenosis detection.

NCT ID: NCT04871204 Recruiting - Gastric Cancer Clinical Trials

Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients With Esophageal or Gastric Cancer

OTIS
Start date: June 16, 2021
Phase: Phase 2
Study type: Interventional

The aim of the study is to clarify whether octreotide therapy can reduce undesired postoperative weight loss, increase health-related quality of life and improve the appetite after surgery for esophageal or gastric cancer.

NCT ID: NCT04869878 Completed - Frailty Clinical Trials

Inter-rater Reliability of the Clinical Frailty Scale in a Swedish Emergency Department Setting

Start date: May 3, 2021
Phase:
Study type: Observational

Frailty is a common clinical syndrome in older adults, which may be assessed through various assessment tools. One frequently used tool is the Clinical Frailty Scale (CFS) which potentially can be adopted for daily use in the Emergency Department and has been appraised for reliability to some extent, but have so far not been evaluated in the Swedish emergency care context. The purpose of this study is to evaluate the inter-rater reliability of the Clinical Frailty Scale (CFS) in a clinical Swedish Emergency Department (ED) setting. Members of multidisciplinary emergency care teams will conduct the assessments individually.